Introduction: serum alpha-fetoprotein (AFP) was routinely employed as a tumor marker for
screening, diagnosis, and treatment follow-up of hepatocellular carcinoma (HCC). However …

AIM: To investigate the biological role of alpha fetoprotein (AFP) and its clinical significance
in carcinogenesis of hepatocellular carcinoma (HCC). METHODS: Clinical analysis of HCC …

The purpose of this study was to conduct a comprehensive study of the clinical correlation
between the alpha-fetoprotein (AFP) level at diagnosis and pathological grades …

Introduction Alpha‐fetoprotein (AFP) has a valuable role in postoperative surveillance for
hepatocellular carcinoma (HCC) recurrence. The utility of pretreatment or baseline AFP …

AIM: To explore the relationship between α-fetoprotein (AFP) and various clinicopathological
variables and different staging system of hepatocellular carcinoma (HCC) thoroughly …

Background Alpha-fetoprotein (AFP) is a biomarker used in clinical management of
hepatocellular carcinoma (HCC), however, approximately 40% of HCC patients do not …

Abstract α‐Fetoprotein (AFP) is often elevated in hepatocellular carcinoma (HCC). This
study was to elucidate the significance and related factors of AFP elevation in HCC in 781 …

Background To investigate the prediction value of preoperative serum alpha-fetoprotein
(AFP) level for the prognosis of hepatocellular carcinoma (HCC), by comparing pathological …

Background The value of alpha-fetoprotein (AFP) as a prognostic indicator in patients with
hepatocellular carcinoma (HCC) has been proposed in recent studies, but the evidence so …

The prognostic impact of serum α-fetoprotein (AFP) level in patients with hepatocellular
carcinoma (HCC) is controversial. This study aimed to investigate the predictive ability of …